Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can potentially infect female reproductive organs. In this study, we investigated the presence of SARS- CoV-2 in cervicovaginal fluid. This study included 31 female patients aged 18–65 years. The presence of SARS-CoV-2 RNA was investigated by RT‒PCR in two separate cervicovaginal swab samples collected from patients 14 days apart. Viral RNA was extracted using Bio-Speedy ®vNAT® Viral Nucleic Acid Buffer (vNAT) solution, and SARS-CoV-2 RNA was analyzed using Bio-Speedy SARS-CoV-2 RT‒qPCR kits in a Bio-Rad CFX96 TouchTM device. First and second cervical swab samples were collected 14 days apart. The SARS-CoV-2 RNA result was negative in all 53 cervicovaginal swab samples collected. Negative SARS-CoV-2 RNA results in cervicovaginal swab sam- ples indicate that coronavirus disease 2019 (COVID-19) is not sexually transmitted. However, the number of studies on this subject and the sample size examined are still insufficient for reaching this conclusion.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA. 2020;324:782-93.
2. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in china, 2019. N Engl J Med. 2020;382:727-33
3. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27:taaa021.
4. Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020;25:278-80.
5. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 72.2020
6. World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations: scientific brief, 27.4.2020
7. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514-23.
8. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
9. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-9.
10. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428-30.
11. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-13.
12. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, china. JAMA Neurol. 2020;77:683-90.
13. Zupin L, Pascolo L, Zito G, et al. SARS-CoV-2 and the next generations: which impact on reproductive tissues?. J Assist Reprod Genet. 2020;37:2399-403.
14. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417-8.
15. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120-8.
16. Qiu L, Liu X, Xiao M, et al. SARS-CoV-2 Is not detectable in the vaginal fluid of women with severe COVID-19 ınfection. Clin Infect Dis. 2020;71:813-817.
17. Cui P, Chen Z, Wang T, et al. Clinical features and sexual transmission potential of SARS-CoV-2 infected female patients: a descriptive study in Wuhan, China. MedRxiv. 2020; doi: https://doi.org/10.1101/2020.02.26.2 0028225
18. Aslan MM, Uslu Yuvacı H, Köse O, et al. SARS-CoV-2 is not present in the vaginal fluid of pregnant women with COVID-19. J Matern Fetal Neonatal Med. 2022;35:2876-8.
19. Li D, Jin M, Bao P, et al. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. 2020;3:e208292.
20. Khoiwal K, Kalita D, Shankar R, et al. Identification of SARS-CoV-2 in the vaginal fluid and cervical exfoliated cells of women with active COVID-19 infection: A pilot study. Int J Gynaecol Obstet. 2021;153:551-3.
21. Schwartz A, Yogev Y, Zilberman A, et al. Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vaginal swabs of women with acute SARS-CoV-2 infection: a prospective study. BJOG. 2021;128:97-100.
22. Chi J, Gong W, Gao Q. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review. Arch Gynecol Obstet. 2021;303:337-45.

APA	Çıplak B, sahin y, AKYOL R, Milletli Sezgin F, Hizmali L, Akca V, Sayhan A, ÇELİK F, Koylu Mızrak Z, eroğlu s, Songur Dagli S, Simsek Y, Kara M (2022). Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study. , 1588 - 1592. 10.5455/medscience.2022.08.181
Chicago	Çıplak Barış,sahin yahya,AKYOL RUKİYE,Milletli Sezgin Fikriye,Hizmali Lokman,Akca Veysel,Sayhan Adviye isil,ÇELİK FATMA,Koylu Mızrak Zeynep,eroğlu sercan,Songur Dagli Selda,Simsek Yavuz,Kara Mustafa Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study. (2022): 1588 - 1592. 10.5455/medscience.2022.08.181
MLA	Çıplak Barış,sahin yahya,AKYOL RUKİYE,Milletli Sezgin Fikriye,Hizmali Lokman,Akca Veysel,Sayhan Adviye isil,ÇELİK FATMA,Koylu Mızrak Zeynep,eroğlu sercan,Songur Dagli Selda,Simsek Yavuz,Kara Mustafa Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study. , 2022, ss.1588 - 1592. 10.5455/medscience.2022.08.181
AMA	Çıplak B,sahin y,AKYOL R,Milletli Sezgin F,Hizmali L,Akca V,Sayhan A,ÇELİK F,Koylu Mızrak Z,eroğlu s,Songur Dagli S,Simsek Y,Kara M Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study. . 2022; 1588 - 1592. 10.5455/medscience.2022.08.181
Vancouver	Çıplak B,sahin y,AKYOL R,Milletli Sezgin F,Hizmali L,Akca V,Sayhan A,ÇELİK F,Koylu Mızrak Z,eroğlu s,Songur Dagli S,Simsek Y,Kara M Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study. . 2022; 1588 - 1592. 10.5455/medscience.2022.08.181
IEEE	Çıplak B,sahin y,AKYOL R,Milletli Sezgin F,Hizmali L,Akca V,Sayhan A,ÇELİK F,Koylu Mızrak Z,eroğlu s,Songur Dagli S,Simsek Y,Kara M "Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study." , ss.1588 - 1592, 2022. 10.5455/medscience.2022.08.181
ISNAD	Çıplak, Barış vd. "Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study". (2022), 1588-1592. https://doi.org/10.5455/medscience.2022.08.181

APA	Çıplak B, sahin y, AKYOL R, Milletli Sezgin F, Hizmali L, Akca V, Sayhan A, ÇELİK F, Koylu Mızrak Z, eroğlu s, Songur Dagli S, Simsek Y, Kara M (2022). Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study. Medicine Science, 11(4), 1588 - 1592. 10.5455/medscience.2022.08.181
Chicago	Çıplak Barış,sahin yahya,AKYOL RUKİYE,Milletli Sezgin Fikriye,Hizmali Lokman,Akca Veysel,Sayhan Adviye isil,ÇELİK FATMA,Koylu Mızrak Zeynep,eroğlu sercan,Songur Dagli Selda,Simsek Yavuz,Kara Mustafa Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study. Medicine Science 11, no.4 (2022): 1588 - 1592. 10.5455/medscience.2022.08.181
MLA	Çıplak Barış,sahin yahya,AKYOL RUKİYE,Milletli Sezgin Fikriye,Hizmali Lokman,Akca Veysel,Sayhan Adviye isil,ÇELİK FATMA,Koylu Mızrak Zeynep,eroğlu sercan,Songur Dagli Selda,Simsek Yavuz,Kara Mustafa Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study. Medicine Science, vol.11, no.4, 2022, ss.1588 - 1592. 10.5455/medscience.2022.08.181
AMA	Çıplak B,sahin y,AKYOL R,Milletli Sezgin F,Hizmali L,Akca V,Sayhan A,ÇELİK F,Koylu Mızrak Z,eroğlu s,Songur Dagli S,Simsek Y,Kara M Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study. Medicine Science. 2022; 11(4): 1588 - 1592. 10.5455/medscience.2022.08.181
Vancouver	Çıplak B,sahin y,AKYOL R,Milletli Sezgin F,Hizmali L,Akca V,Sayhan A,ÇELİK F,Koylu Mızrak Z,eroğlu s,Songur Dagli S,Simsek Y,Kara M Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study. Medicine Science. 2022; 11(4): 1588 - 1592. 10.5455/medscience.2022.08.181
IEEE	Çıplak B,sahin y,AKYOL R,Milletli Sezgin F,Hizmali L,Akca V,Sayhan A,ÇELİK F,Koylu Mızrak Z,eroğlu s,Songur Dagli S,Simsek Y,Kara M "Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study." Medicine Science, 11, ss.1588 - 1592, 2022. 10.5455/medscience.2022.08.181
ISNAD	Çıplak, Barış vd. "Cervicovaginal coronavirus disease 2019 (COVID-19) positivity: A pilot study". Medicine Science 11/4 (2022), 1588-1592. https://doi.org/10.5455/medscience.2022.08.181